AHA Letter on Drug Price Transparency Bill

AHA letter to Ways and Means Committee on the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113.

Key Resources

Related Resources

Testimony
AHA Statement on Legislative Proposals to be Considered Before Energy and Commerce Committee On Sept. 18
Public
Letter/Comment
AHA Letter to Reps. Fischbach and Pence Expressing Support of Congressional Review Act (CRA) Resolutions
Public
AHA Center for Health Innovation Market Scan
3 Ways GLP-1 Drugs Could Impact Your Hospital’s Future
Testimony
AHA Statement: Legislative Proposals To Increase Medicaid Access And Improve Program Integrity
Public
Letter/Comment
AHA Letter to Senate Finance Committee for May 1 Hearing on Change Healthcare Cyberattack
Letter/Comment
AHA Letter to House E&C Subcommittee for May 1 Hearing on Change Healthcare Cyberattack